NCT03812900View on ClinicalTrials.gov

Superiority of Newly Developed Over Basic Echinacea Formulations for the Treatment of Respiratory Tract Infections

PHASE2/PHASE3CompletedINTERVENTIONAL

Enrollment

246

Participants

Timeline

Start Date

November 27, 2018

Primary Completion Date

June 5, 2019

Study Completion Date

June 7, 2019

Conditions

Respiratory Tract Infections

Interventions

DRUG

Echinacea purpurea alcoholic extract

Different galenic forms with Echinacea purpurea alcoholic extract from herb and roots (95:5%)

Trial Locations (1)

Unknown

Cantonal Hospital St. Gallen, Sankt Gallen

All Listed Sponsors

collaborator

Cantonal Hospital of St. Gallen

OTHER

collaborator

Labormedizinisches Zentrum Dr. Risch

INDUSTRY

lead

A. Vogel AG

INDUSTRY

NCT03812900 - Superiority of Newly Developed Over Basic Echinacea Formulations for the Treatment of Respiratory Tract Infections | Biotech Hunter | Biotech Hunter